ERBB2 and breast carcinoma: Additionally, the CAR‐NK cell‐derived exosomes and transferrin receptor‐binding peptides (T7) can form nanoplatforms capable of traversing the blood–brain barrier and selectively exerting anti‐tumour effects on HER2‐positive breast cancer cells in the brain [101].